title: Resveratrol induces p53 and suppresses myocardin-mediated vascular smooth muscle cell differentiation.
abstract: Resveratrol (RSVL), a polyphenolic antioxidant present in red wine, has been shown to provide cardiovascular protection by improving endothelial function and reducing myocardial ischemia. However, little is known about how RSVL affects vascular smooth muscle cells (VSMCs) differentiation. RSVL blocks VSMC proliferation in vitro and neointimal formation following artery injury in vivo. Thus, one might expect that RSVL will promote VSMC differentiation. Unexpectedly, our results in this study show that RSVL induces VSMCs phenotypic modulation; this is characterized by suppressed transcription of SMC-specific marker genes Tagln, Acta2, Myh11, and Smtn in a dose-dependent and time-dependent manner in cultured VSMCs. Consistent with previous studies, RSVL induces the nuclear translocation of p53 and the expression of p53-responsive genes such as Cdkn1a, Gadd45a, Gadd45, and Fas. In an effort to identify the molecular mechanisms whereby RSVL represses VSMC differentiation, we found that RSVL inhibits the transcription of Myocardin (myocd) and Srf, the key VSMC transcriptional regulators. However, knockingdown and overexpressing p53 did not affect RSVL-induced VSMCs phenotypic modulation: this suggests that RSVL may induce VSMC dedifferentiation via p53-independent mechanisms. This study provides the first evidence showing that RSVL induces VSMC dedifferentiation by regulating Myocardin and SRF-mediated VSMC gene transcription.
authors.affiliation: Department of Internal Medicine, Wayne State University, Detroit, MI 48201, USA.
authors.forename: Jian-Pu
authors.initials: JP
authors.lastname: Zheng
authors.forename: Donghong
authors.initials: D
authors.lastname: Ju
authors.forename: Hong
authors.initials: H
authors.lastname: Jiang
authors.forename: Jianbin
authors.initials: J
authors.lastname: Shen
authors.forename: Maozhou
authors.initials: M
authors.lastname: Yang
authors.forename: Li
authors.initials: L
authors.lastname: Li
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects*; D032389:Myocytes, Smooth Muscle / Q000166:cytology / Q000187:drug effects*; D009687:Nuclear Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D051381:Rats; D000077185:Resveratrol; D026362:Serum Response Factor / Q000037:antagonists & inhibitors / Q000235:genetics; D015398:Signal Transduction / Q000187:drug effects; D013267:Stilbenes / Q000494:pharmacology*; D015534:Trans-Activators / Q000037:antagonists & inhibitors* / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000502:physiology*; D000099251:Myocardin
chemical_list: D009687:Nuclear Proteins; D000077185:Resveratrol; D026362:Serum Response Factor; D013267:Stilbenes; D015534:Trans-Activators; D016159:Tumor Suppressor Protein p53; D000099251:Myocardin
references.citation: Arch Med Res. 2008 Feb;39(2):155-61
references.pmid: 18164958
references.citation: Biochem Biophys Res Commun. 2003 Nov 14;311(2):546-52
references.pmid: 14592451
references.citation: PLoS One. 2008;3(11):e3707
references.pmid: 19002260
references.citation: Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1263-9
references.pmid: 18420994
references.citation: Circulation. 2002 Sep 24;106(13):1652-8
references.pmid: 12270858
references.citation: Circ Res. 2003 May 2;92(8):856-64
references.pmid: 12663482
references.citation: Biochem Pharmacol. 2004 Feb 15;67(4):777-85
references.pmid: 14757178
references.citation: J Immunol. 2000 Jun 15;164(12):6509-19
references.pmid: 10843709
references.citation: J Clin Invest. 1994 Jun;93(6):2393-402
references.pmid: 8200973
references.citation: Exp Mol Pathol. 2010 Feb;88(1):52-7
references.pmid: 19874818
references.citation: Circ Res. 2007 Mar 16;100(5):607-21
references.pmid: 17363707
references.citation: Nature. 2003 Sep 11;425(6954):191-6
references.pmid: 12939617
references.citation: Recent Pat Cardiovasc Drug Discov. 2007 Jun;2(2):133-8
references.pmid: 18221111
references.citation: Circ Res. 2004 Apr 16;94(7):863-5
references.pmid: 15044321
references.citation: Biochem Biophys Res Commun. 2006 Jul 21;346(1):367-76
references.pmid: 16759640
references.citation: Development. 2006 Nov;133(21):4245-56
references.pmid: 17021041
references.citation: Cell. 2001 Jun 29;105(7):851-62
references.pmid: 11439182
references.citation: Eur J Pharmacol. 2005 May 16;515(1-3):1-9
references.pmid: 15878161
references.citation: Toxicol Sci. 2004 Dec;82(2):614-9
references.pmid: 15329443
references.citation: J Nutr. 2005 Dec;135(12):2767-73
references.pmid: 16317118
references.citation: Dev Biol. 1997 Jul 15;187(2):311-21
references.pmid: 9242426
references.citation: Cardiovasc Res. 2010 Feb 1;85(3):514-9
references.pmid: 19815564
references.citation: Arch Biochem Biophys. 2009 Jun 15;486(2):95-102
references.pmid: 19514131
references.citation: Circulation. 1992 Dec;86(6):1977-86
references.pmid: 1333373
references.citation: Dev Cell. 2010 Apr 20;18(4):510-25
references.pmid: 20412767
references.citation: J Cell Biol. 1996 Mar;132(5):849-59
references.pmid: 8603917
references.citation: BMC Genomics. 2007 Jul 16;8:237
references.pmid: 17634102
references.citation: Am J Physiol Cell Physiol. 2007 Jan;292(1):C70-81
references.pmid: 16928770
references.citation: J Vasc Res. 2010;47(2):168-80
references.pmid: 19851078
references.citation: Exp Cell Res. 2009 Oct 15;315(17):2953-62
references.pmid: 19665018
references.citation: J Pharmacol Exp Ther. 2010 Apr;333(1):34-42
references.pmid: 20089806
references.citation: Circ Res. 2010 Apr 30;106(8):1351-62
references.pmid: 20224039
references.citation: J Vasc Surg. 2005 Dec;42(6):1190-7
references.pmid: 16376213
references.citation: Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H1027-37
references.pmid: 19168719
references.citation: Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1164-71
references.pmid: 19478208
references.citation: Curr Opin Genet Dev. 2004 Oct;14(5):558-66
references.pmid: 15380248
references.citation: Thromb Res. 2002 Aug 15;107(3-4):141-5
references.pmid: 12431480
references.citation: J Biol Chem. 2005 Mar 11;280(10):9719-27
references.pmid: 15623517
references.citation: Lancet. 1993 Feb 20;341(8843):454-7
references.pmid: 8094487
references.citation: Circ Res. 2005 Feb 18;96(3):280-91
references.pmid: 15718508
references.citation: Biochem Biophys Res Commun. 2000 Jul 21;274(1):61-7
references.pmid: 10903896
references.citation: J Clin Invest. 2000 Nov;106(9):1139-47
references.pmid: 11067866
references.citation: J Intern Med. 2006 Sep;260(3):192-210
references.pmid: 16918817
references.citation: J Thorac Cardiovasc Surg. 2009 Dec;138(6):1392-9
references.pmid: 19931668
references.citation: Biochem Pharmacol. 2001 Oct 15;62(8):1113-24
references.pmid: 11597580
references.citation: Biochem Pharmacol. 2000 Apr 1;59(7):865-70
references.pmid: 10718345
references.citation: Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H859-66
references.pmid: 18065527